Home > Financial Ratios > INDOCO REMEDIES

INDOCO REMEDIES
EV/Core EBITDA

    Back to All Ratios
INDOCO REMEDIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 29.7314.3411.4411.2112.77

What is the latest EV/Core EBITDA ratio of INDOCO REMEDIES ?

The latest EV/Core EBITDA ratio of INDOCO REMEDIES is 29.73 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202529.73
Mar202414.34
Mar202311.44
Mar202211.21
Mar202112.77

How is EV/Core EBITDA of INDOCO REMEDIES Trending?

Years EV/Core EBITDA % Change
Mar2025 29.73
107.32
Mar2024 14.34
25.35
Mar2023 11.44
2.05
Mar2022 11.21
-12.22
Mar2021 12.77 -

Other Financial Ratios of INDOCO REMEDIES


Compare EV/Core EBITDA ratio of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹1,791.1 Cr -3.5% -13.7% -12.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹434,999.0 Cr 3.1% 6.2% 13.5% Stock Analytics
DIVIS LABORATORIES ₹169,139.0 Cr -1% 3.3% 14.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,791.0 Cr -0% 10% 45.6% Stock Analytics
DR REDDYS LABORATORIES ₹109,664.0 Cr -0.6% 3.3% 16.4% Stock Analytics
CIPLA ₹107,685.0 Cr -2% -0.6% -6.1% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

-3.5%

-13.7%

-12.1%

SENSEX

-4.6%

-7.5%

6%


You may also like the below Video Courses